Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...
Buntanetap improved cognition in pTau217-positive early AD patientsThe drug reduced neurotoxic proteins as well as biomarkers of ...
The MarketWatch News Department was not involved in the creation of this content. SANTA ANA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) ("NKGen" or the "Company"), a ...
Circular Genomics, a biotechnology company revolutionizing neurological and psychiatric precision medicine through ...
Biotech researchers are making strides in areas from living neural networks to novel cancer vaccines, but regulatory acceptance lags behind scientific innovation. Disputes over the use of biomarkers ...
Researchers at the University of Geneva have built a molecular system that can tell the difference between a cancer cell and a healthy one, then selectively destroy the tumor cell while leaving normal ...
Troculeucel, a cryopreserved autologous, non-genetically modified NK cell product, appears to cross the blood brain barrier (BBB) via CXCR3, to reduce neuroinflammation via a simple IV administration.
Detecting Low-Abundance Biomarkers in Blood and CSF: Challenges and Solutions High-sensitivity biomarker platforms are revolutionizing clinical neuroscience, but significant challenges remain. The ...
Pooled analyses in patients with moderate Alzheimer’s show dose-related cognitive benefit and signs of durability. 100% of patients remained stable or improved, with 50% improving from moderate to ...